Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Deville, Curtiland ^a,c   Both, Stefan ^a   Bui, Viet ^a   Hwang, Wei Ting ^b   Tan, Kay See ^b   Schaer, Mattia ^a   Tochner, Zelig ^a   Vapiwala, Neha ^a  

^a Department of Radiation Oncology ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

IMRT; Prostate cancer; Rectal balloon; Toxicity

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDIARRHEAL AGENT; GONADORELIN DERIVATIVE; SPASMOLYTIC AGENT; WATER;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BALLOON; BLADDER INJURY; BLADDER NECK STENOSIS; CANCER PATIENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; DYSURIA; ENDORECTAL BALLOON; ENTERITIS; GASTROINTESTINAL TOXICITY; HEMORRHOID; HIGH RISK PATIENT; HISTOGRAM; HUMAN; IMAGE GUIDED INTENSITY MODULATED RADIATION THERAPY; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PROCTITIS; PROSTATE; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION; TREATMENT PLANNING; URGE INCONTINENCE; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; URINE RETENTION; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; UROGENITAL SYSTEM;

EID: 84861337023     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-76     Document Type: Article

References (22)

1. D' Amico AV, Manola J, Loffredo M, et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Biol Phys 2001, 51:1431-1436. 10.1016/S0360-3016(01)02663-3, 11728704.
2. Both S, Wang KK, Plastaras JP, Deville C, Bar Ad V, Tochner Z, Vapiwala N. Real-Time Study of Prostate Intrafraction Motion During External Beam Radiotherapy With Daily Endorectal Balloon. Int J Radiat Oncol Biol Phys 2010,
3. Patel RR, Orton N, Tomé WA, Chappell R, Ritter MA. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol 2003, 67:285-294. 10.1016/S0167-8140(03)00056-2, 12865176.
4. Van Lin EN, Hoffmann AL, van Kollenburg P, Leer JW, Visser AG. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:565-576. 10.1016/j.ijrobp.2005.05.010, 16168848.
5. Li XA, Yu C, Holmes T. A systematic evaluation of air cavity dose perturbation in megavoltage x-ray beams. Med Phys 2000, 27:1011-1017. 10.1118/1.598966, 10841404.
6. Ebert MA, Spry NA. Dose perturbation by air cavities in megavoltage photon beams: implications for cavity surface doses. Australas Radiol 2001, 45:205-210. 10.1046/j.1440-1673.2001.00900.x, 11380365.
7. Teh BS, Dong L, McGary JE, Mai WY, Grant W, Butler EB. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim 2005, 30:25-30. 10.1016/j.meddos.2004.10.005, 15749008.
8. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000, 89:1800-1809. 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D, 11042576.
9. Song JS, Court LE, Cormack RA. Monte Carlo calculation of rectal dose when using an intrarectal balloon during prostate radiation therapy. Med Dosim 2007, 32:151-156. 10.1016/j.meddos.2006.11.002, 17707193.
10. Van Esch A, Tillikainen L, Pyykkonen J, Tenhunen M, Helminen H, Siljamäki S, Alakuijala J, Paiusco M, Lori M, Huyskens DP. Testing of the analytical anisotropic algorithm for photon dose calculation. Med Phys 2006 Nov, 33(11):4130-4148.
11. Vargas C, Mahajan C, Fryer A, et al. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2007, 69:1110-1116. 10.1016/j.ijrobp.2007.04.075, 17967305.
12. Cancer Therapy Evaluation Program Common terminology criteria for adverse events, version 3.0 2006, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Washington, DC, Cancer Therapy Evaluation Program.
13. Barry MJ, Coffey DC, Fitzpatrick J, et al. Recommendations of the International Consensus Committee concerning patient evaluation for research studies. Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH) 1991, 279-281. Paris Scientific Communication International, Channel Islands, Cockett ATK, Aso Y, Chatelain C.
14. Bastasch MD, Teh BS, Mai WY, McGary JE, Grant WH, Butler EB. Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer. Am J Clin Oncol 2006, 29(1):8-11. 10.1097/01.coc.0000195099.26957.63, 16462495.
15. Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010, 78(3):763-772. 10.1016/j.ijrobp.2009.08.043, 20171807.
16. Goldner G, Geinitz H, Wachter S, et al. 3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment. Wien Klin Wochenschr 2006, 118:224-229. 10.1007/s00508-006-0588-z, 16794760.
17. Van Lin EN, van der Vight LP, Witjes JA, Huisman HJ, Leer JW, Visser AG. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. Int J Radiat Oncol Biol Phys 2005, 61:278-288. 10.1016/j.ijrobp.2004.09.042, 15629621.
18. Teh BS, Mai WY, Uhl BM, Augspurger ME, Grant WH, Lu HH, Woo SY, Carpenter LS, Chiu JK, Butler EB. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys. 2001, 49(3):705-712. 10.1016/S0360-3016(00)01428-0, 11172952.
19. Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in rad iation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010, 76(3):123-129. 10.1016/j.ijrobp.2009.03.078, 19386426.
20. Harsolia A, Vargas C, Yan D, Brabbins D, Lockman D, Liang J, Gustafson G, Vicini F, Martinez A, Kestin LL. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. Int J Radiat Oncol Biol Phys 2007, 69(4):1100-1109. 10.1016/j.ijrobp.2007.04.076, 17967304.
21. Karlsdottir A, Johannessen DC, Muren LP, Wentzel-Larsen T, Dahl O. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 2004, 71:43-53. 10.1016/j.radonc.2004.01.014, 15066295.
22. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000 , 56(6):899-905. 10.1016/S0090-4295(00)00858-X, 11113727.